ICU Medical, Inc.
ICUI
주식 순위
#4024
ICU Medical, Inc., operating globally through its subsidiaries, is a medical... ICU Medical, Inc., operating globally through its subsidiaries, is a medical technology firm that specializes in the development, manufacture, and sale of devices for both infusion therapy and critical care. Their extensive product line for infusion therapy encompasses: Needlefree Connectors: Such as the MicroClave, MicroClave Clear, and NanoClave brands. Catheter Maintenance & Disinfection: Including Neutron patency devices and SwabCap/SwabTip disinfecting caps. Hemodialysis Solutions: Like Tego connectors and ClearGuard HD antimicrobial caps. Hazardous Drug Handling: With closed system transfer devices (ChemoClave, ChemoLock) and the Diana compounding system for safe preparation. They also provide a comprehensive range of intravenous (IV) solutions, diluents, and irrigation fluids, available in diverse packaging options like flexible containers and pour bottles. These include common formulations such as sodium chloride, dextrose, balanced electrolytes, lactated ringer's, mannitol, and sterile water, alongside specialized irrigation solutions like acetic acid and glycine. In medication management, ICU Medical offers sophisticated infusion pumps, including the Plum 360 and LifeCare PCA brands. Its advanced ICU Medical MedNet software enhances medication safety by integrating smart pumps with hospital electronic health records (EHRs), asset tracking, and alarm notification platforms. Accompanying professional services are also provided. For critical care environments, their portfolio features: Hemodynamic Monitoring: Systems like Cogent 2-in-1 and CardioFlo. Cardiac Output & Oximetry: TDQ, OptiQ, and TriOx catheters. Blood Pressure Transducers: Such as Transpac. Blood Sampling Systems: Including the SafeSet closed blood sampling and conservation systems. The company distributes its products to a wide spectrum of healthcare providers, including acute care hospitals, wholesalers, ambulatory clinics, and various alternate site facilities such as outpatient clinics, home healthcare services, and long-term care centers. Established in 1984, ICU Medical maintains its headquarters in San Clemente, California.
주가
$161.56
마지막 동기화: 2026-10-19
시가총액
$4.04B
변동 (1일)
-0.87%
변동 (1년)
37.69%
국가
US
거래 ICU Medical, Inc. (ICUI)
카테고리
Healthcare
ICU Medical, Inc. (ICUI)의 P/E 비율
October 2026 기준 P/E 비율 TTM: 135.58
ICU Medical, Inc.의 최신 재무 보고서와 주가에 따르면 현재 P/E (TTM) 비율은 135.58입니다. 2023년 말 기준 P/E 비율은 -81.03였습니다.
ICU Medical, Inc.의 P/E 비율 기록 (2000 ~ 2026)
매년 말 P/E 비율
| 연도 | P/E 비율 | 변화 |
|---|---|---|
| 2026 (TTM) | 135.58 | -521.56% |
| 2024 | -32.16 | -60.32% |
| 2023 | -81.03 | 60.14% |
| 2022 | -50.60 | -203.68% |
| 2021 | 48.80 | -5.46% |
| 2020 | 51.62 | 35.11% |
| 2019 | 38.21 | -77.82% |
| 2018 | 172.27 | 179.12% |
| 2017 | 61.72 | 63.43% |
| 2016 | 37.76 | -4.95% |
| 2015 | 39.73 | -16.40% |
| 2014 | 47.53 | 105.27% |
| 2013 | 23.15 | 10.29% |
| 2012 | 20.99 | 50.62% |
| 2011 | 13.94 | -13.23% |
| 2010 | 16.06 | -20.47% |
| 2009 | 20.20 | 4.71% |
| 2008 | 19.29 | -13.44% |
| 2007 | 22.28 | -2.47% |
| 2006 | 22.85 | -14.46% |
| 2005 | 26.71 | -64.32% |
| 2004 | 74.86 | 253.96% |
| 2003 | 21.15 | -19.09% |
| 2002 | 26.14 | 5.58% |
| 2001 | 24.76 | 16.30% |
| 2000 | 21.29 | 0.00% |
유사 기업 또는 경쟁사의 P/E 비율
| 회사 | P/E 비율 | P/E 비율 차이 | 국가 |
|---|---|---|---|
| 47.48 | -64.98% |
US
|
|
| 27.43 | -79.77% |
FR
|
|
| - | - |
JP
|
|
| 56.89 | -58.03% |
US
|
|
| - | - |
CH
|
P/E 비율 읽는 방법
P/E 비율은 회사의 주가와 주당순이익 간의 관계를 측정합니다.
낮지만 양수인 P/E는 현재 가치 대비 높은 수익을 내고 있는 저평가된 기업을 의미합니다. 높은 음수(0에 가까운) P/E는 큰 손실을 나타냅니다.
P/E가 30을 초과하거나 음수인 기업은 일반적으로 '성장주'로 간주되며, 투자자들은 향후 수익성 개선을 기대합니다.
양의 P/E가 10 미만인 기업은 일반적으로 '가치주'로 간주되며, 이미 매우 수익성이 높고 향후 큰 성장은 기대되지 않습니다.